ROSCO Panel Recommends New Approach on Rosacea Diagnosis by Phenotype

[Admin 0]

The RRDi endorses the phenotype based treatment for rosacea proposed by the ROSCOE Panel in November 2016. 

“Given the overlap of rosacea features across subtypes and the fact that no single treatment completely addresses all rosacea features, the current approach of diagnosing and treating rosacea by subtype may hinder individualised patient management. A new approach is needed to bring us closer to helping each and every rosacea patient receive the right treatment according to their signs and symptoms.” Jerry Tan, MD 

“While the rosacea management landscape has advanced, the current subtype-based view of the disease can hinder progress by limiting the way we consider treatment options. These new ROSCO recommendations should help to make a positive impact on future treatment development and ultimately help improve the lives of people with rosacea through a symptom-led approach.” Esther J. van Zuuren, MD

Global ROSacea COnsensus (ROSCO) expert panel calls for new approach to diagnosis and treatment of rosacea to improve outcomes for patients, BusinessWire

Br J Dermatol. 2016 Oct 8. doi: 10.1111/bjd.15122. 
Updating the diagnosis, classification and assessment of rosacea: Recommendations from the global ROSacea COnsensus (ROSCO) panel.
Tan J, Almeida L, Bewley A, Cribier B, Dlova N, Gallo R, Kautz G, Mannis M, Oon H, Rajagopalan M, Steinhoff M, Thiboutot D, Troielli P, Webster G, Wu Y, van Zuuren E, Schaller M.

For more info on this subject, read the articles, Classification Of Rosacea Remains Controversial • Shortcomings in rosacea diagnosis and classification

Download: pdf

[Admin 0]

"The panel agreed on phenotype-based treatments for signs and symptoms presenting in individuals with rosacea." Dr. Martin Schaller serves on the ROSCO panel as well as the RRDi MAC. 

Br J Dermatol. 2016 Nov 12. doi: 10.1111/bjd.15173. 
Rosacea treatment update: Recommendations from the global ROSacea COnsensus (ROSCO) panel.
Schaller M, Almeida L, Bewley A, Cribier B, Dlova N, Kautz G, Mannis M, Oon H, Rajagopalan M, Steinhoff M, Thiboutot D, Troielli P, Webster G, Wu Y, van Zuuren E, Tan J.

[Admin 0]

Treatment guidelines updated for patients with rosacea, November 21, 2016, Medical Press

Phenotype-based treatments recommended for rosacea, Health Day News, Clinical Advisor

Expert Panel Provides Recommendations for Rosacea Treatment, MPR

[Admin 0]

"A recent study in the British Journal of Dermatology makes a case for treating and managing rosacea based on the clinical presentation, or phenotype."

Global Consensus on Rosacea Treatments by Phenotype, by Jennifer Newton, Medical News Bulletin

[Admin 0]

The ROSCO panel that created the phenotype classification which the RRDi has endorsed are from all over the world  (by last name, first name initial, country): 

Almeida LM, Brazil

Bewley A, United Kingdom

Cribier B, France

Dlova NC, South Africa

Gallo R, USA

Kautz G, Germany

Mannis M, USA

Oon HH, Singapore

Rajagopalan M, India

Schaller M. Germany

Steinhoff M, Ireland

Tan J, Canada

Thiboutot D, USA

Troielli P, Argentina.

Webster G, USA

Wu Y, China

van Zuuren EJ, Netherlands